Xiaoguang M. Shi

36 Sanhao Street
Shenyang, 110004, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 53 publications

HTD1801 in Combination with Metformin for Type 2 Diabetes.

HTD1801 in Combination with Metformin for Type 2 Diabetes.

Journal: NEJM evidence

Published: June 07, 2026

Spatial transcriptomic analysis identifies a necroptosis-prone thyroid follicular cell state in Hashimoto's thyroiditis.

Spatial transcriptomic analysis identifies a necroptosis-prone thyroid follicular cell state in Hashimoto's thyroiditis.

Journal: Frontiers in immunology

Published: June 07, 2026

HRS-7535 for Type 2 Diabetes Inadequately Controlled With Metformin: A Randomized Clinical Trial.

HRS-7535 for Type 2 Diabetes Inadequately Controlled With Metformin: A Randomized Clinical Trial.

Journal: JAMA network open

Published: June 03, 2026

Association between hypothyroidism, levothyroxine replacement and kidney function outcomes: a systematic review and meta-analysis.

Association between hypothyroidism, levothyroxine replacement and kidney function outcomes: a systematic review and meta-analysis.

Journal: Frontiers in endocrinology

Published: March 28, 2026

Metallothionein's role in oxidative stress: A pathway to innovative treatments.

Metallothionein's role in oxidative stress: A pathway to innovative treatments.

Journal: Pharmacological research

Published: March 22, 2026

PCSK9 Inhibitors: A Potential Priority Choice for Lipid Management in Patients with Diabetic Kidney Disease.

PCSK9 Inhibitors: A Potential Priority Choice for Lipid Management in Patients with Diabetic Kidney Disease.

Journal: Drugs

Published: July 28, 2025

Efficacy and safety of cAMP-biased GLP-1 receptor agonist ecnoglutide versus dulaglutide in patients with type 2 diabetes and elevated glucose concentrations on metformin monotherapy (EECOH-2): a 52-week, multicentre, open-label, non-inferiority, randomised, phase 3 trial.

Efficacy and safety of cAMP-biased GLP-1 receptor agonist ecnoglutide versus dulaglutide in patients with type 2 diabetes and elevated glucose concentrations on metformin monotherapy (EECOH-2): a 52-week, multicentre, open-label, non-inferiority, randomised, phase 3 trial.

Journal: The lancet. Diabetes & endocrinology

Published: March 30, 2025

Efficacy and safety of a biased GLP-1 receptor agonist ecnoglutide in adults with overweight or obesity: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.

Efficacy and safety of a biased GLP-1 receptor agonist ecnoglutide in adults with overweight or obesity: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.

Journal: The lancet. Diabetes & endocrinology

Published: March 25, 2025

Assessing thyroid health: phenotypic age compared to chronological age.

Assessing thyroid health: phenotypic age compared to chronological age.

Journal: Frontiers in endocrinology

Published: March 15, 2025

Comprehensive assessment on the association of dietary vitamins with all-cause and cardiovascular mortality among individuals with prediabetes: evidence from NHANES 1999-2018.

Comprehensive assessment on the association of dietary vitamins with all-cause and cardiovascular mortality among individuals with prediabetes: evidence from NHANES 1999-2018.

Journal: Food & function

Published: September 16, 2024

Thyrotropin reference interval in older adults.

Thyrotropin reference interval in older adults.

Journal: Endocrine connections

Published: August 27, 2024

Factors affects the implementation of active surveillance therapy for low-risk papillary thyroid microcarcinoma.

Factors affects the implementation of active surveillance therapy for low-risk papillary thyroid microcarcinoma.

Journal: Chinese medical journal

Published: February 22, 2024

Showing 1-12 of 53

Last Updated: 09/26/2026